[Irinotecan for the treatment of metastatic colorectal cancer].

Abstract:

:In a dozen years of development, irinotecan (CPT11) became one of major therapeutics in the taking care of the metastatic colorectal cancer (CCRM). First used in monotherapy every three weeks, irinotecan has been later developed in association with 5FU and folinic acid according to two modalities of administration (bolus schedule administred weekly or infused schedule every two weeks). This association is now validated both in first and second line. Infused schedule (Folfiri) seems to introduce the best ratio of efficacy/tolerance. The association with the anti VEGF antibody (Avastin), bevacizumab) is promising. Moreover the association of the irinotecan with the anti EGFR antibody (Erbitux)), cetixumab) has show a efficacy in third line after progression under an protocol with irinotecan. Combinations with oxaliplatine (Irox, Irinox) or (Folfoxiri, Folfirinox) still remain in the course of appreciation notably in neoadjuvant context. An increment of dose seems accomplishable in monotherapy or in combination with/AF (high Folfiri doses) with a notable increment of responses rates. Nevertheless this strategy must again show a true clinical interest. Finally they are at promising developments in the fields of the irinotecan pharmacogenetic and pharmacogenomic.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Assenat E,Duffour J,Ychou M

subject

Has Abstract

pub_date

2006-05-01 00:00:00

pages

507-15

issue

5

eissn

0007-4551

issn

1769-6917

journal_volume

93

pub_type

杂志文章,评审
  • [Uncommon bladder tumours].

    abstract::Bladder tumours are frequent with around 10,000 new cases each year in France. Less than 500 of these cases are not transitional cell carcinoma, the most frequent pathological aspect. The identification of these pathological patterns requires an initial biopsy through transurethral resection. Sarcomatoid, squamous and...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1097

    authors: Boyle H,Fléchon A,Droz JP

    更新日期:2010-01-01 00:00:00

  • Mise à jour 2016 des recommandations pour la pratique clinique de Nice/Saint-Paul-de-Vence dans le cancer de l’ovaire et du col de l’utérus à un stade avancé.

    abstract::UPDATED 2016 RECOMMENDATIONS FOR THE CLINICAL PRACTICE OF NICE/SAINT-PAUL-DE-VENCE IN OVARIAN CANCER AND ADVANCED CERVICAL CANCER: Since the first edition of the 2012-2013 Clinical Practice Recommendations Nice-Saint-Paul for gynecological cancers, the management of ovarian cancer has become more complex with a better...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/S0007-4551(17)30156-X

    authors: Joly F,Querleu D,Namer M,Pujade-Lauraine E

    更新日期:2017-05-01 00:00:00

  • [Percutaneous ablation of metastases: where are we and new techniques].

    abstract::When a metastatic disease is localized and slowly evolving either spontaneously or after a general treatment, a local treatment may be proposed. For about 15 years, image-guided percutaneous ablation has been developed which allows to treat tumors with temperature modifications. These mini-invasive techniques may be r...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2013.1728

    authors: Palussière J,Buy X,Fonck M

    更新日期:2013-04-01 00:00:00

  • [New molecular classification of colorectal cancer, pancreatic cancer and stomach cancer: Towards "à la carte" treatment?].

    abstract::This review reports 3 of recently published molecular classifications of the 3 main gastro-intestinal cancers: gastric, pancreatic and colorectal adenocarcinoma. In colorectal adenocarcinoma, 6 independent classifications were combined to finally hold 4 molecular sub-groups, Consensus Molecular Subtypes (CMS 1-4), lin...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2016.05.007

    authors: Dreyer C,Afchain P,Trouilloud I,André T

    更新日期:2016-07-01 00:00:00

  • [Radiotherapy for sarcoma: hadrontherapy, for whom and what for?].

    abstract::The radiobiological properties of the hadrons (neutrons, protons, carbon ions) led to their therapeutic use in sarcomas, as a referent therapy or as an alternative to photon therapy. An extensive review of the literature has been conducted to assess the present indications and the perspectives for hadrontherapy. Compa...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1125

    authors: Pommier P,Sunyach MP,Hu Y,Amsalem E,Claude L,Moncort-Boulch D,Toutenu P,Balosso J

    更新日期:2010-06-01 00:00:00

  • [Sarcomas of soft tissue in the adult. Therapeutical indications].

    abstract::Treatment of soft-tissue sarcomas has to deal simultaneously with three goals: 1) to obtain the control of the primary tumor, 2) to preserve the function, and 3) to treat the micrometastatic disease. For local control, surgery remains the most efficient treatment, but the extent of the resection of macroscopically non...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Bui NB

    更新日期:1988-01-01 00:00:00

  • [Urinary incontinence and sexual dysfunction after treatment of localized prostate cancer: Results from a population aged less than 65years old].

    abstract:INTRODUCTION:An increasing number of patients with prostate cancer (PC) are diagnosed and treated. The aim of this study was to investigate urinary incontinence (UI) and sexual dysfunction (SD) two years after treatment for localized prostate cancer (PC). METHODS:This study followed all cases of localized PC diagnosed...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2016.09.011

    authors: Bessaoud F,Orsini M,Iborra F,Rebillard X,Faix A,Soulier M,Daurès JP,Trétarre B

    更新日期:2016-10-01 00:00:00

  • [Molecular mechanisms of oncogenic transformation: what's new?].

    abstract::During the past two years, new molecular targets have been discovered which link cell cycle, cell proliferation and cellular growth. It has become more and more evident that whereas gain-of-function mutations in specific genes can lead to cancer, genomic instability plays also an important role in tumour progression. ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Blanchard JM

    更新日期:2002-01-01 00:00:00

  • [Ondansetron: a specific 5-HT3 serotonin receptor inhibitor, a new antiemetic in oncology].

    abstract::Serotonin (5-Hydroxytryptamine) seems to play a dominant role in triggering vomiting induced by cytotoxic agents through the stimulation of 5-HT3 receptors. They have been observed in the GI tract as well as in the brain (area postrema). Ondansetron is a specific antagonist of 5-HT3 serotonin receptors. Its anti-emeti...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: d'Allens H,Aubert B,Bons J,Pappo M

    更新日期:1991-01-01 00:00:00

  • [The detection of sentinel lymph node in nuclear medicine].

    abstract::The isotopic detection of the sentinel node is undergoing a fast development in breast cancer and melanoma. It requires a good collaboration between a surgeon and a nuclear medicine specialist. Although the method is now well defined for melanoma, several options remain possible for breast cancer. The injected dose an...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Maublant J,Cachin F,Mesta D,Geissler B

    更新日期:2002-07-01 00:00:00

  • [What's new in the treatment of cancer pain?].

    abstract::Improvements have been made recently in the treatment of cancer pain. First of all, this symptom is better recognized and evaluated in cancer patients. Then new therapeutic options have became available in France : tramadol, WHO level II analgesic, for intermediate to severe pain; gabapentine, a new anticonvulsivant d...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Di Palma M,Poulain P,Pichard E

    更新日期:2004-01-01 00:00:00

  • [New challenge in head and neck oncology surgery: the transoral robotic surgery].

    abstract::Robotic assisted surgery is a new field of developing program for many specialties. As to head and neck oncology, the new procedure potentially offers alternatives to conventional surgery with decreased morbidity. The aim of this article is a description of the state of the art via a review of the literature. We empha...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2009.1022

    authors: Mallet Y,Moriniere S,Ceruse P,El Bedoui S

    更新日期:2010-01-01 00:00:00

  • [Use of alternative donors for allogeneic haematopoietic cell transplantation in lymphoid neoplasms: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

    abstract::Despite great improvements in the outcome of patients with lymphoma, some may still relapse or present with primary refractory disease. In these situations, allogeneic haematopoietic cell transplantation (allo-HCT) is a potentially curative option, in particular in the case of relapse after autologous stem cell transp...

    journal_title:Bulletin du cancer

    pub_type: 共识发展会议,杂志文章,实务指引,评审

    doi:10.1016/j.bulcan.2017.08.008

    authors: Gauthier J,Chantepie S,Bouabdallah K,Jost E,Nguyen S,Gac AC,Damaj G,Duléry R,Michallet M,Delage J,Lewalle P,Morschhauser F,Salles G,Yakoub-Agha I,Cornillon J

    更新日期:2017-12-01 00:00:00

  • [ALL in adult patients: Contribution and limits of pediatric management].

    abstract::For two decades, the prognostic of adult patients with ALL was improved based on pediatric-inspired protocols. These approaches based on less myelosuppressive drugs have led to improved response rates, decreased relapse rates, with a benefit in survival observed in patients aged up to 50-60-years-old. Therapeutic inte...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2020.07.008

    authors: Rabian F,Boissel N

    更新日期:2020-09-24 00:00:00

  • [Recent data on the immunology of tumors. Mechanisms of escape of immunological control. Role of suppressor cells].

    abstract::Cells in spleens from tumor bearing animals were found to inhibit in vitro reactivity of lymphocytes to a variety of stimulants. These suppressor cells inhibited the stimulation of normal lymphocytes by mitogens : P.H.A.-Con A-L.P.S. They were adherent cells, bore immunoglobulins at their surface and did not bear the ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lespinats G,Poupon MF

    更新日期:1976-04-01 00:00:00

  • Herpes virus production as a marker of repair in ultraviolet irradiated human skin cells of different origin.

    abstract::When confluent human skin cultures are ultraviolet (UV)-irradiated before infection with Herpes Simplex type 1 virus (HSV), their capacity to support virus growth is impaired. When the time interval between UV-exposure and infection is increased up to 36 hours, different recoveries of HSV production capacity are obser...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Coppey J,Moreno G,Nocentini S

    更新日期:1978-01-01 00:00:00

  • [The surrogate: Partner in the shared decision-making].

    abstract:UNLABELLED:The legislative process of the surrogate appears to be unclear to health professionals and to patients and next of kin. To better adapt this process to the clinical practice our objective was here to document how the persons designated as surrogate perceived their role and how they described the difficulties...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2016.03.003

    authors: Sarradon-Eck A,Capodano G,Bureau E,Julian-Reynier C

    更新日期:2016-07-01 00:00:00

  • [Patients' information in percutaneous core breast biopsy].

    abstract::Information takes a large part of patient's perceptions of the procedure. If the information is adapted, patients tolerate the procedure well. We point out indications and explain the different types of procedure. For infraclinical masses, sonographically guided automated core needle biopsy removes samples. Sonographi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Barreau B,Tastet S,Lakdja F,Henriquès C,Valentin F,Labat MJ,Dilhuydy MH

    更新日期:2005-03-01 00:00:00

  • [Clinical activity spectrum of irinotecan].

    abstract::Irinotecan (CPT11), a topoisomerase I inhibitor, is a new cytotoxic agent with a broad spectrum of clinical activity. Two main schedules have been studied and produce similar activity and side-effects: the "european" one--350 mg/m2 every 21 days-, and the "japanese-north american" one where CPT11 is given at a weekly ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Cottu PH,Extra JM,Lerebours F,Espie M,Marty M

    更新日期:1998-12-01 00:00:00

  • [Novel conventional therapies in onco-hemathology].

    abstract::Cytogenetic, molecular and phenotyping features of malignant hematologic diseases succeeded in improving their management by a more accurate stratification of patients according to several groups of risk and by providing a rational for targeted therapy. Three major types of treatment (excluding cellular therapy) are c...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1412

    authors: Baleydier F,Domenech C,Thomas X

    更新日期:2011-08-01 00:00:00

  • [Postmastectomy pain syndrome evidence based guidelines and decision trees].

    abstract::A multidisciplinary expert group had reviewed all scientific data available of post mastectomy pain syndrome. Seventy six publications were retained and thirty evidence based diagnosis, treatment and follow-up recommendations are listed. Few of theses recommendations are classed level A. Datas analysis make possible t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,实务指引,评审

    doi:

    authors: Labrèze L,Dixmérias-Iskandar F,Monnin D,Bussières E,Delahaye E,Bernard D,Lakdja F

    更新日期:2007-03-01 00:00:00

  • [Pharmacological consequences of the targeting of epidermal growth factor receptor].

    abstract::Through clearly identified molecular mechanisms, EGFR targeting leads to cell physiology modifications as cell proliferation, apoptosis and DNA repair. These mechanisms can explain the proper activity of EGFR targeting drugs but also represent a strong rational basis on which several experimental studies have been des...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Milano G,Magné N

    更新日期:2003-11-01 00:00:00

  • Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease.

    abstract::To show the nature and magnitude of EKG anomalies subsequent to 5-fluorouracil (5FU) administration and determine whether the onset is dependent on a pre-existing cardiovascular pathological condition. 1,350 patients were treated by 5FU between 1995 and 2000. EKG were recorded in all patients before each administratio...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Tsibiribi P,Descotes J,Lombard-Bohas C,Barel C,Bui-Xuan B,Belkhiria M,Tabib A,Timour Q

    更新日期:2006-03-01 00:00:00

  • [Metastatic stomach cancer: Clinical trials in Asia and in Occident].

    abstract::Although cytotoxic chemotherapy is the main therapeutic option to treat gastric cancer in the metastatic setting, molecular targeted agents have recently been introduced in an effort to improve survival outcomes which in average do not exceed 1 year. Trastuzumab and ramucirumab, antibodies directed against HER2 and VE...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.07.012

    authors: Bui QL,Grazziotin-Soares D,Hasiniatsy RE,Trinh HS,Richard S,Lotz JP,Gligorov J,Khalil A

    更新日期:2018-10-01 00:00:00

  • [Renovascular effects of antiangiogenic drugs].

    abstract::During the last decade, inhibitors of the vascular endothelial growth factor (VEGF) were developed for the treatment of cancer. Many anti-VEGF are available but the issue is still the same: to inhibit the effect of the VEGF on their receptors. There are two main classes, depending on the mechanism of action by blockin...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2016.05.005

    authors: Deray G,Janus N,Aloy B,Launay-Vacher V

    更新日期:2016-07-01 00:00:00

  • Evaluation of multidrug resistant phenotype by flow cytometry with monoclonal antibodies and functional tests.

    abstract::Multidrug resistant (MDR) phenotype is characterized by a defect in drug accumulation caused by overexpression of a transmembrane glycoprotein, the P-glycoprotein (P-gp). MDR phenotype can be characterized either with monoclonal antibodies raised against P-gp or with functional tests, most often based on the incorpora...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lizard G,Maynadié M,Roignot P,Lizard-Nacol S,Poupon MF

    更新日期:1995-03-01 00:00:00

  • [Linac-based stereotactic radiosurgery and radiotherapy].

    abstract::Stereotactic radiation therapy, consisting in irradiating the tumor with a high dose per fraction, has a therapeutic potential because of excellent local control. This technique requires a high accuracy level in order to minimize the risk of normal tissue toxicity. Initially used for cerebral localization, the stereot...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1144

    authors: Ayadi M,Ginestet C,Gassa F,Claude L,Mazeron JJ

    更新日期:2010-07-01 00:00:00

  • [Cognitive impairments and breast cancer: a critical review of the literature].

    abstract::Since the 1980's, women treated for breast cancer are reporting moderate cognitive impairments during and after chemotherapy. These cognitive impairments may be related to chemotherapy but also to hormone therapy, psychological distress, fatigue... This work is a critical review of the literature, which reports types ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0818

    authors: Vandenbossche S,Fery P,Razavi D

    更新日期:2009-02-01 00:00:00

  • [Chemotherapy combining vindesine, thiotepa and methotrexate in metastatic breast cancer after failure of a combination containing anthracycline. Results of a prospective phase II trial].

    abstract::Twenty-six patients with metastatic breast cancer where treated, after failure of a first line chemotherapy including an anthracycline, with a second line combination of vindesine, methotrexate and thiotepa. Overall tolerance of this treatment was good. There were one complete response and two partial responses. The a...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Comoz M,Chevallier B,Bastit P

    更新日期:1988-01-01 00:00:00

  • [Changes in methylation of tumor cells: a new in situ quantitative approach on interphase nuclei and chromosomes].

    abstract::DNA methylation is known to be related to the regulation of gene expression. DNA methylation patterns are modified in tumors compared to normal tissue, and in some cases, these variations are linked to cancer progression. Molecular biology techniques are generally used to evaluate DNA methylation status. We describe h...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Veilleux C,Bernardino J,Gibaud A,Niveleau A,Malfoy B,Dutrillaux B,Bourgeois CA

    更新日期:1995-11-01 00:00:00